161 related articles for article (PubMed ID: 32756121)
1. Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases.
Huang Z; Hu C; Tong Y; Fan Z; Zhao C
Medicine (Baltimore); 2020 Jul; 99(31):e21339. PubMed ID: 32756121
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
3. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
[TBL] [Abstract][Full Text] [Related]
4. Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung Cancer Receiving Radiotherapy: A Population-Based Study.
Li P; Luo J; Zheng Z; Meng L; Zhang A; Cao W; Gong X
Cancer Control; 2024; 31():10732748241255212. PubMed ID: 38769789
[TBL] [Abstract][Full Text] [Related]
5. Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
Zhang C; Mao M; Guo X; Cui P; Zhang L; Xu Y; Li L; Han X; Peltzer K; Xiong S; Baklaushev VP; Wang X; Wang G
BMC Cancer; 2019 Mar; 19(1):238. PubMed ID: 30876473
[TBL] [Abstract][Full Text] [Related]
6. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of nomograms to predict early death in non-small cell lung cancer patients with brain metastasis: a retrospective study in the SEER database.
Yang F; Gao L; Wang Q; Gao W
Transl Cancer Res; 2023 Mar; 12(3):473-489. PubMed ID: 37033346
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database.
Zhang J; Zhang J
BMC Pulm Med; 2023 Oct; 23(1):413. PubMed ID: 37899470
[TBL] [Abstract][Full Text] [Related]
9. Analysis of survival benefit from primary tumor resection and individualized prediction of overall survival for lung cancer patients with bone metastasis: Worth it or not?
Tong Y; Jiang L; Gong Y; Zhu D; Zhao D
Asian J Surg; 2024 Jan; 47(1):333-349. PubMed ID: 37741753
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
Huang X; Hu P; Yan F; Zhang J
Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
[No Abstract] [Full Text] [Related]
11. Diagnostic and prognostic factors, and two nomograms for endometrial cancer patients with bone metastasis: A large cohort retrospective study.
Yang F; Zhao R; Huang X; Wang Y
Medicine (Baltimore); 2021 Sep; 100(36):e27185. PubMed ID: 34516519
[TBL] [Abstract][Full Text] [Related]
12. CT-based radiomics for predicting brain metastases as the first failure in patients with curatively resected locally advanced non-small cell lung cancer.
Sun F; Chen Y; Chen X; Sun X; Xing L
Eur J Radiol; 2021 Jan; 134():109411. PubMed ID: 33246270
[TBL] [Abstract][Full Text] [Related]
13. Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
Ding Y; Jiang R; Chen Y; Jing J; Yang X; Wu X; Zhang X; Xu J; Xu P; LiuHuang SC; Lu Z
BMC Cancer; 2021 Apr; 21(1):420. PubMed ID: 33863315
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
15. Construction and Validation of Two Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of NSCLC Patients with Bone Metastasis.
Dong Q; Deng J; Mok TN; Chen J; Zha Z
Int J Gen Med; 2021; 14():9261-9272. PubMed ID: 34880665
[TBL] [Abstract][Full Text] [Related]
16. Two novel clinical tools to predict the risk of bone metastasis and overall survival in esophageal cancer patients: a large population-based retrospective cohort study.
Jiang L; Tong Y; Jiang J; Zhao D
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11759-11777. PubMed ID: 37407847
[TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
[TBL] [Abstract][Full Text] [Related]
18. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a Prognostic Nomogram for Lung Adenocarcinoma with Brain Metastases.
Huang Z; Tong Y; Tian H; Zhao C
World Neurosurg; 2020 Sep; 141():e700-e709. PubMed ID: 32531436
[TBL] [Abstract][Full Text] [Related]
20. A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC).
Wu Z; Ouyang C; Peng L
Med Sci Monit; 2020 Jun; 26():e923231. PubMed ID: 32479428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
